‘India primary destination for cardiac surgery, alternative medicine’

The Federation of Indian Chambers of Commerce and Industry (FICCI), in association with IMS Health, on Monday launched a knowledge paper titled ‘Medical Value Travel in India: Enhancing Value in MVT’, at the second International Summit on Medical Value Travel (MVT) Advantage Healthcare India (AHCI 2016) in Greater Noida. As per the study, India is one the key MVT destinations in Asia with over 500,000 foreign patients seeking treatment. 

It revealed that cost effectiveness, superior clinical outcomes and alternative medicine are key parameters on which India differentiates itself from other MVT destinations. The FICCI - IMS Health study was commissioned in order to carry out an unbiased evaluation of India vis-a-vis other popular MVT destinations across Asia and developed markets. 

The aim was also to understand key considerations for MVT patients and define guidelines that can strengthen as well as improve India’s position thereby emerging as one of the most preferred MVT destinations across the world. The study is an effort to bring together key stakeholders of the MVT ecosystem including policy makers, providers and facilitators and help them work in conjunction to help India emerge as “The Provider to the World”. 

Bhavdeep Singh, Chair, FICCI Medical Value Travel Committee and CEO - Fortis Healthcare said, “Over the last decade, India has grown to become a sought after destination for medical value travel because it has proven to be superior across multiple factors that determines the overall quality of care. However, to position ourselves as leading providers of quality healthcare, the medical value travel stakeholders in India will need to consolidate our efforts and strategise on how to leverage the available opportunities”.